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Nitric oxide modulates expression of matrix metalloproteinase-9 predominantly regulated through the action of matrix
in rat mesangial cells. metalloproteinases (MMPs). These neutral proteases be-
Background. High-output levels of nitric oxide (NO) are pro- long to a unique family of metal-dependent enzymes thatduced by rat mesangial cells (MCs) in response to proinflamma-
have in common the ability to degrade specifically com-tory cytokines such as interleukin-1b (IL-1b) and tumor necro-
ponents of connective tissue matrices, including colla-sis factor-a (TNF-a) by the inducible isoform of NO synthase
(iNOS). We tested modulatory effects of NO on the expression gens, laminins, gelatin, and proteoglycans.
and activities of matrix metalloproteinases-9 and -2 (MMP-9 Although MMPs are important participants in many
and MMP-2), respectively. Temporal and spatial expression of physiologic processes such as wound healing, angio-these MMPs and their specific inhibitors, the tissue inhibitors
genesis, or tissue remodeling, their altered expression isof metalloproteinases (TIMPs), seems to be critical in the ex-
associated with severe pathologic conditions, most prom-tensive extracellular matrix (ECM) remodeling that accompa-
nies sclerotic processes of the mesangium. inently rheumatoid arthritis [1]. In the kidney, dysregula-
Methods and Results. Using the NO donors S-Nitroso-N- tion of homeostatic ECM turnover is known to cause
acetyl-D,L-penicillamine (SNAP) and DETA-NONOate, we impairment of glomerular filtration. The accumulationfound strong inhibitory effects of NO mainly on the IL-1b–
of ECM proteins, for example, is an important featureinduced MMP-9 mRNA levels. NO on its own had only weak
of many progressive renal diseases such as diabetic ne-effects on the expression of MMP-9 and MMP-2. The addition
of the NOS inhibitor NG-monomethyl l-arginine (L-NMMA) phropathy and glomerulosclerosis [2].
dose dependently increased steady-state mRNA levels of cyto- The regulation of MMPs occurs on different levels,
kine-induced MMP-9, suggesting that endogenously produced including gene expression, processing of the inactive pro-NO exerts tonic inhibition of MMP-9 expression. MMP-9 activ-
enzymes by removal of a 10 kD fragment and by inhibi-ity in conditioned media from MCs costimulated with IL-1b
tion of the active enzymes by their endogenous inhibitorsand NO donor contained less gelatinolytic activity than media
of cells treated with IL-1b alone. Exogenously added NO did delineated as tissue inhibitors of matrix metallopro-
not alter gelatinolytic activity of MMP-9 in cell-free zymo- teinases (TIMPs). Increased expression of MMPs, partic-
graphs. The expression levels of TIMP-1 were affected by NO ularly MMP-2 and MMP-9, which are collectively de-similarly to the expression of MMP-9.
nominated as gelatinases, by proinflammatory cytokinesConclusion. We conclude that NO modulates cytokine-
such as interleukin-1b (IL-1b), tumor necrosis factor-amediated expression of MMP-9 and TIMP-1 in rat MCs in
culture. Our results provide evidence that NO-mediated atten- (TNF-a), and g-interferon has been described for differ-
uation of MMP-9 gelatinolytic activity is primarily due to a ent cell types, including articular chondrocytes [3], syno-
reduced expression of MMP-9 mRNA, and not the result of vial cells [4], and glomerular mesangial cells (MCs) [5].direct inhibition of enzymatic activity.
MCs have certain macrophage-like properties and cru-
cially contribute to inflammatory processes of the renal
Deposition of extracellular matrix (ECM) in the mes- glomerulus. Upon stimulation, MCs release biologically
angium represents a tightly regulated balance between active substances, particularly IL-1b and TNF-a, cyto-
synthesis and degradative processes of matrix proteins kines that help to perpetuate the formation of other
inflammatory mediators, such as eicosanoids, growth fac-
tors, or nitric oxide (NO) [6]. Previously, we have re-Key words: cytokines, inflammation, glomerular mesangial cells, in-
terleukin-1b, tissue inhibitor. ported that inflammatory cytokines induce inducible NO
synthase (iNOS) in glomerular MCs mainly on the tran-Received for publication February 9, 1999
scriptional level [7–9]. Furthermore, recent evidence hasand in revised form June 2, 1999
Accepted for publication August 20, 1999 been obtained that NO itself can modulate gene expression
of inflammatory mediators such as IL-8, macrophage- 2000 by the International Society of Nephrology
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induced protein 1a (MIP 1a) [10] and iNOS [11]. In U36476). The following primers were used: 59-CTT
AGA TCA TTC TTC AGT GCC-39 (sense) and 5-9GATthis study, we have investigated the possible modulatory
effects of NO on cytokine-induced gelatinase expression CCA CCT TCT GAG ACT TCA-39 (antisense). The
blunt-ended polymerase chain reaction (PCR) fragmentand the corresponding enzyme activities in rat MCs.
was cloned into the EcoRV cloning site of pBluescript-II
KS1 (Stratagene GmbH, Heidelberg, Germany) to gen-
METHODS
erate “pKS-MMP-9 rat.” A cDNA insert of 1.2 kb of rat
Cell culture 72 kD type collagenase was generated using internal
primers from the complete sequence of rat MMP-2Rat glomerular MCs were cultured as described pre-
viously [12]. MCs were grown in RPMI 1640 supple- mRNA (accession No. X71466) and cloned into EcoRV-
cut pBluescript-II KS1 to generate “pKS-MMP-2 rat.”mented with 10% heat-inactivated fetal calf serum (FCS),
2 mmol glutamin, 5 ng/mL insulin, 100 U/mL penicillin, The following primers were used: 59-ATT ATC CCA
TGA TGA CAT CAA-39 (sense) and 59-AGC AGCand 100 mg/mL streptomycin. Serum-free preincubations
were performed in Dulbecco’s modified Eagle’s medium CCA GCC AGT CTG AT-39 (antisense). A 0.52 kb
cDNA insert for rat TIMP-1 was generated using internal(DMEM) supplemented with 0.1 mg/mL of fatty acid-
free bovine serum albumin for 24 hours before cytokine primers of a partial coding sequence of TIMP-1 mRNA
(accession No. L29512). The primers were 59-CAG ACGtreatment. For the experiments, 3.0 to 5.0 3 106 cells per
10 cm culture dish were used. MCs were used between GCG TTC TGC AAC TCG (sense) and 59-AGA CCC
AAG GGA TTG CCA GGT-39 (antisense). PCR frag-passages 8 and 19. All supplements were purchased from
GIBCO/BRL, Life Technologies (Eggenstein, Germany). ments were then cloned into EcoRV-cut pBluescript-II
KS1 to generate “pKS-TIMP-1 rat.”The NO donors S-Nitroso-N-acetyl-D,L-penicillamine
(SNAP) and DETA NONOate and the NOS inhibitor
Northern blot analysisNG-monomethyl l-arginine (L-NMMA) were from Alexis
Biochemicals (Gru¨nberg, Germany). N2, 29-O-Dibutyryl- Total cellular RNA was extracted from MCs using the
Trizol reagent (GIBCO/BRL, Life Technologies). Afterguanosine39:59-cyclic monophosphate was from Sigma-
Aldrich (Deisenhofen, Germany). The determination of ultraviolet cross-linking, 20 mg of total RNA were succes-
sively hybridized to the 32P-labeled SacI/KpnI-digestedcell numbers was done by the use of a Neubauer cham-
ber. The amount of dead cells was determined by trypan- cDNA clones described earlier in this article, thereby
liberating inserts of corresponding fragment sizes. cDNAblue exclusion.
Cell cytotoxicity was measured by the use of a Cytotox- probes (2 3 106 cpm/mL) were radioactively labeled with
a32PdCTP (Amersham Buchler GmbH & CoKG, Braun-icity Detection Kit (Roche Diagnostics GmbH, Mann-
heim, Germany). For determination of the gelatinolytic schweig, Germany) by random priming. To correct for
variations in RNA amounts, blots were finally rehy-activity of cellular supernatants, 1.0 to 1.5 3 106 MCs
were grown on six-well plates, and experiments were bridized with a 32P-labeled SacI/KpnI insert from the
GAPDH cDNA clone. Membranes used for RNA trans-performed in triplicates.
fers were obtained from NENe Life Science Products
Nitrite measurements in mesangial cell supernatants (Boston, MA, USA). Northern blots were maximally
stripped and rehybridized three times. Specific signalsNitrite contents of cellular supernatants were mea-
sured as a readout for NOS activity. Confluent MCs (1.0 were quantitated densitometrically using an automated
detector system BAS 1500 from Fujifilm (Raytest, Strau-to 1.5 3 106 cells) on six-well plates were incubated in
DMEM without FCS and were stimulated with or with- benhardt, Germany).
out agents for the indicated time periods. After the incu-
SDS-PAGE zymographybations, 100 mL of supernatants were mixed with 100
mL of Griess reagent (Merck, Darmstadt, Germany). Gelatinolytic activity of proteins from cellular super-
natants was assessed by electrophoresis in the presenceThe absorbance at 540 nm with a reference wavelength
at 595 nm was measured, and nitrite concentration was of sodium dodecyl sulfate (SDS) in 10% polyacrylamide
gel electrophoresis (PAGE) containing 0.1% gelatin Bdetermined using a calibration curve with sodium nitrite
standards. (Sigma-Aldrich). To ensure that the supernatants were
derived from equal cell numbers, for each experimental
cDNA clones and plasmids condition, cell counts were obtained separately. In gen-
eral, 10 to 20 mL of culture media were loaded on gelsA cDNA insert of 0.7 kb for rat 92 kD type IV colla-
genase was generated by reverse transcription from directly after the addition of 2 3 sample buffer con-
taining 4% SDS, 0.005% bromphenol blue, and 20%mRNA of MCs stimulated with IL-1b using internal prim-
ers from the complete sequence of rat mRNA (deposited glycerol. Denaturated proteins were renatured by ex-
changing SDS with Triton in two 15-minute incubationsin the Genbank/EMBL Databases under accession No.
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with 2.5% Triton X-100 after gel runs. The gels were IL-1b, we observed a strong inhibitory effect of SNAP
on the steady-state level of MMP-9 mRNA (6.9-foldsubsequently incubated overnight at 378C in developing
buffer containing 0.2 mol NaCl, 5 mmol CaCl2, and induction with IL-1b vs. 1.9-fold induction after 36 hours
of coincubation with IL-1b and SNAP; Fig. 1 A, B).0.02% Brij 35 (Sigma). At the end of incubations, gels
were stained with staining solution containing 30% metha- Similar results were obtained with the NO-donor DETA
NONOate (data not shown).nol, 10% acetic acid, and 0.5% Coomassie G250 (Sigma-
Aldrich). Destaining was performed in the same solution Although both type IV collagenases have similar sub-
strate specificities, their expression pattern can markedlywithout Coomassie for several hours. Proteins with gela-
tinolytic activity were visualized as areas of lytic activity differ. Therefore, we determined in parallel steady-state
mRNA levels using a MMP-2–specific cDNA probe.on an otherwise blue gel. Migration properties of pro-
teins were determined by comparison with that of a Compared with MMP-9, MMP-2 shows a higher constitu-
tive expression as we found a corresponding band al-prestained, full-range rainbow protein marker (Amer-
sham). Photographs of the gels were scanned by an im- ready under nonstimulated conditions (Fig. 1A). Al-
though the treatment with IL-1b led to an increasedaging densitometer system from Bio-Rad Laboratories
(Mu¨nchen, Germany). Metal dependence of gelatino- accumulation of MMP-2 mRNA (1.7 6 0.2-fold induc-
tion at 36 hours; mean 6 sd, N 5 4), it was less pro-lytic activities was confirmed by incubation of duplicate
gels in the presence of 0.01 mol/L ethylenediaminetetra- nounced than the increase in MMP-9 mRNA, suggesting
that MMP-2 expression is close to a maximum alreadyacetic acid (EDTA) in the developing buffer, which re-
sulted in the disappearance of lytic bands. under control conditions. A high level of constitutive
expression of MMP-2 in glomerular mesangial cells has
Cell-free incubation experiments also been reported by Harendza et al [16]. In some exper-
iments, SNAP on its own exerted weak inhibitory effectsIn these experiments, the effects of exogenously given
NO on MMP activities were tested in the conditioned on basal MMP-2 mRNA levels (0.8 6 0.3-fold induction;
mean 6 sd, N 5 4), which, however, did not reach statis-culture medium harvested from untreated or IL-1b–
stimulated MCs, respectively. Incubations were carried tical significance. In contrast, SNAP significantly reduced
the IL-1b–caused increase in the MMP-2 mRNA levelout in a total volume of 100 mL using final concentrations
of NO donors between 250 and 500 mmol/L. At the end (1.7 6 0.2, N 5 4, without SNAP vs. 0.6 6 0.4, N 5 4,
in the presence of SNAP; mean 6 sd). This inhibitoryof each incubation, samples were mixed with 2 3 sample
buffer and were loaded on gels for SDS-PAGE zymogra- effect of NO was maximal between 24 and 36 hours of
coincubation and was somewhat weaker at later timephy, as described earlier in this article.
points (Fig. 1A). Similar results were obtained with
Statistical analysis DETA NONOate (data not shown).
Results are expressed as means 6 sd. The data are
Exogenous nitric oxide down-regulates thepresented as x-fold induction compared with control condi-
interleukin-1b–induced mRNA level of TIMP-1tions or compared with IL-1b–stimulated values (N). Statis-
tical analysis was performed using the Student’s t-test. P We next checked mRNA levels of TIMP-1, an endoge-
nous MMP-9 inhibitor that acts through the binding tovalues , 0.05 or , 0.01 were considered significant.
the latent proenzyme, thereby preventing its activation
[17]. Interestingly, looking at long-term kinetic experi-
RESULTS
ments, we found that TIMP-1 followed a similar expres-
Effects of exogenous nitric oxide on mRNA levels sion pattern as MMP-9 (Fig. 1A). IL-1b strongly in-
of metalloproteinases-9 and -2 creased TIMP-1 mRNA levels up to fivefold as compared
with the basal expression levels. IL-1b–induced mRNAThe family of MMPs includes the two genetically dis-
tinct 92 and 72 kD type IV collagenases MMP-9 and levels peaked after 36 hours of stimulation (Fig. 1B).
Whereas the NO donor on its own caused a moderateMMP-2, respectively, which are expressed in MCs [13–
15]. IL-1b strongly induced MMP-9 mRNA level in MCs 1.8-fold increase of basal TIMP-1 mRNA levels, there
was a marked attenuation of TIMP-1 mRNA levels inwith a maximal accumulation observed between 36 and
48 hours of stimulation (Fig. 1A), thus confirming previ- cytokine-stimulated cells, which was most prominent
after 36-hour coincubation with SNAP (Fig. 1B).ous observations [15]. The data for the 36-hour coincuba-
tion of cells with IL-1b and NO donor are shown in more To test whether inhibitory effects on cytokine-induced
MMP-9 and MMP-2 mRNA levels were paralleled by de-detail in Figure 1B.
Using the NO donor SNAP (500 mmol/L) in time kinetic creased activities of corresponding enzymes, we performed
SDS-PAGE zymography. Assessing equal amounts ofexperiments, we found that the NO donor on its own
had no discernible effect on basal MMP-9 mRNA levels conditioned media from the cells used for RNA isolation,
we found that gelatinolytic activity of a band migrating(Fig. 1 A, B). However, when given in combination with
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Fig. 1. (A) Effects of exogenous nitric oxide
(NO) on expression and activity of matrix
metalloproteinases (MMPs) in rat mesangial
cells. Time course of steady-state level of
mRNA of MMP-9, MMP-2, and tissue in-
hibitor of metalloproteinase-1 (TIMP-1) in
mesangial cells (MCs) following treatment
with interleukin-1b (IL-1b, 2 nmol/L) with
or without S-Nitroso-N-acetyl-D,L-penicilla-
mine (SNAP, 500 mmol/L). Twenty micro-
grams of total cellular RNA were hybridized
successively to a 32P-labeled cDNA inserts
from KS-MMP-9, KS-MMP-2, and KS-
TIMP-1, respectively. The size of the corre-
sponding mRNA is indicated at the right end
of the figure. Equivalence of loading in differ-
ent lanes was ascertained by rehybridization
to a GAPDH probe. Similar results were ob-
tained in two additional independent experi-
ments. (B) Statistical analysis of MMP-9 and
TIMP-1 mRNA levels after 36 hours of stimu-
lation. Data represent means 6 sd (N 5 3).
*P # 0.05; **P # 0.01 compared with control
or to IL-1b-stimulated conditions (#). (C) To
test for corresponding lytic activities of gela-
tinases from the experiment shown in (A), 10
mL of cellular supernatants from correspond-
ing culture plates were assayed by SDS-PAGE
zymography. The zymogen is displayed as a
negative to clarify lytical intensities of MMP-9.
(D) Time course induction of nitrite produc-
tion in supernatants of MCs upon stimulation
with IL-1b (2 nmol/L). The results indicate
nitrite levels after the indicated time periods
and are expressed as means 6 sd of four ex-
periments. **P # 0.01 compared with control.
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Fig. 1. (Continued)
at 92 kD tightly correlated with the changes in the steady- creasing concentrations of SNAP. As shown in Figure 2,
state levels of MMP-9 mRNA (Fig. 1C). As seen for the none of the concentrations used alone had strong effects
MMP-9 mRNA, a maximum of lytic activity was found on the basal expressions of MMP-9 and TIMP-1, respec-
after 48 hours of cytokine treatment. Two constitutive tively. However, the steady-state level of both mRNAs
lytical bands migrating at 72 and 66 kD, respectively, induced by IL-1b was reduced up to 20% already at a
were only marginally influenced by SNAP. Gelatinolytic concentration of 100 mmol/L SNAP. Increased inhibition
activities of all bands were not observed in the presence was reached by increasing SNAP concentration from 250
of EDTA, indicating that they represent metallopro- to 500 mmol/L to 1.0 mmol/L. Maximal inhibition was
teinase activities (data not shown). obtained using 1.0 mmol/L of SNAP (90% inhibition).
To determine whether the NO concentrations that we For further experiments, we chose 250 and 500 mmol/L
used were comparable to those endogenously produced of SNAP. At these concentrations, none of the NO do-
through the induction of iNOS, the nitrite release of MCs nors used exerted any detectable effects on cell viability
was measured following a time course induction with (data not shown).
IL-1b. Figure 1D shows the average of triplicate mea-
surements of total nitrite in cell supernatants. A marked Inhibition of NOS strongly increases levels of MMP-9
and steadily increasing nitrite production was observed and TIMP-1 mRNA
between 16 and 72 hours of stimulation. The amounts
To determine whether the observed inhibitory effectsof NO produced by cytokine-stimulated MCs are thus
of NO on MMP-9 mRNA levels are of physiologic rele-well in the range released by the exogenous NO donors
vance, cells were coincubated with IL-1b in the presenceused in our experiments.
of L-NMMA, a potent enzymatic inhibitor of NO synthe-
Dose-dependent inhibition of IL-1b–induced MMP-9 sis. As we have shown previously, IL-1b is a strong activa-
and TIMP-1 mRNA level by SNAP tor of iNOS expression in rat MCs and leads to genera-
tion of high amounts of NO by MCs [7, 9, 18]. As shownTo test for dose dependence of the NO donor SNAP,
MCs were stimulated for 24 hours with IL-1b plus in- in Figure 3, IL-1b–mediated induction of MMP-9 and
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Fig. 2. Expression of MMP-9 and TIMP-1
mRNA following treatment of MCs with IL-
1b and different concentrations of SNAP.
MCs were treated for 24 hours with the indi-
cated concentrations of SNAP in the absence
(2) or presence of 2 nmol/L of IL-1b (1). The
same blot was successively hybridized with the
indicated 32P-labeled cDNA inserts.
Fig. 3. L-NMMA increases IL-1b–induced
MMP-9 and TIMP-1 mRNA level. Quiescent
MCs were treated with vehicle (control),
IL-1b (2 nmol/L), and SNAP (500 mmol/L) and
L-NMMA (3 mmol/L), as indicated (A). After
48 hours of stimulation, cells were harvested
for total RNA preparation. Twenty micro-
grams of RNA were hybridized successively
to cDNA inserts coding for rat MMP-9 and
rat TIMP-1. To correct for variations in RNA
loading, the blot was rehybridized with a
GAPDH probe. Similar results were obtained
in two additional independent experiments.
Concentrations of nitrite in cellular superna-
tants are given at the bottom of the gel. Dose-
dependent enhancement of IL-1b–induced
MMP-9 and TIMP-1 mRNA accumulation by
L-NMMA (B). MCs were treated for 48 hours
with the indicated concentrations of L-NM-
MA in the absence (2) or presence of 2 nmol
of IL-1b (1).
TIMP-1 mRNA level was substantially amplified by treat- Nitric oxide modulation of MMP-9 activity correlates
with the alterations of the MMP-9 mRNA levelment of cells with L-NMMA. The increase of IL-1b–
induced MMP-9 and TIMP-1 mRNA level caused by Next we tested whether the modulation of the cyto-
L-NMMA occurred in a dose-dependent manner (Fig. kine-induced MMP-9 mRNA level by NO also affected
3B). Maximal stimulatory effects were reached above gelatinolytic content in conditioned media from MCs.
1.0 mmol/L of L-NMMA. L-NMMA at any of the tested Figure 4A shows a representative zymographic analysis
concentrations did not have any effects on the mRNA of serum-free conditioned medium obtained from con-
trol and stimulated MCs. To exclude that differenceslevel when given alone (Fig. 3B).
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Fig. 5. Gelatinolytic activity of MMP-9 and MMP-2 in conditioned
media from MCs treated with DETA NONOate and IL-1b. MCs were
incubated with the indicated substances for 48 hours. Aliquots of 20
mL of cell supernatants were collected and directly subjected to gel
electrophoresis. The data shown are representative of three indepen-
dent experiments giving similar results.
in gelatolytic contents were due to differences in cell
numbers, we also determined total cell numbers under
each of the experimental condition tested; no significant
changes in cell numbers were observed (data not shown).
Under control conditions, we observed two major lytical
bands migrating at 72 and 66 kD, respectively. The upper
band at 72 kD corresponded to latent MMP-2 (also desig-
nated progelatinase-A), whereas the lower band at 66
kD represented the activated form of MMP-2 [19]. Both
isoforms, independent of their activation status, are able
to degrade gelatin in the zymogen assay [20]. Stimulation
of MCs with 2 nmol/L of IL-1b caused an 8.3-fold induc-
tion of a band migrating at 92 kD with strong gelatinolytic
activity (Fig. 4A). Under the conditions tested, the lytic
activity of MMP-2 was much more intensive then that
of MMP-9. However, as gelatin is not the only substrate
of either MMP enzyme, gelatinolytic activity measured
in this assay did not necessarily reflect activities of
MMP-2 and MMP-9 toward relevant substrates in vivo.
Conditioned medium from cells treated with SNAP
alone did not display any MMP-9 activity, thus confirm-
ing the findings made by Northern blot analysis. Superna-
tants from MCs treated with IL-1b plus SNAP showed
Fig. 4. Gelatinolytic activity of MMP-9 in conditioned media from cells
treated with SNAP and IL-1b. MCs were incubated with the indicated
substances (IL-1b, 2 nmol/L, SNAP, 500 mmol/L). Aliquots of 10 mL
of cell culture supernatants were collected after 48 hours of stimulation
and were directly subjected to gel electrophoresis (A). Migration prop-
erties were determined using standard molecular weight markers. The
lower panel displays a short-term exposed image of the same gel to
clarify lytical intensities of MMP-2 gelatinase activities. The data shown
are representative of three independent experiments. Measurement of
nitrite levels given at the bottom of the gel was done by the Griess
assay. (B) Statistical analysis of MMP-9 and MMP-2 gelatinolytic activi-
ties after 48 hours of stimulation, as was assessed by SDS-PAGE zymog-
raphy. Data represent means 6 sd (N 5 4). *P # 0.05; **P # 0.01
compared with control or to IL-1b–treated conditions (#).
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Fig. 6. Gelatinolytic activity of MMP-9 in con-
ditioned media from MCs is increased if cells
have been cotreated with L-NMMA. MCs were
incubated with the indicated substances for 48
hours (IL-1b, 2 nmol/L; L-NMMA, 3 mmol/L).
Lytical activity of an IL-1b–inducible band mi-
grating at 92 kD was determined using stan-
dard molecular weight markers. Similar results
were obtained in three separate experiments.
The zymogram is displayed as a negative to
clarify lytical intensities of MMP-9 gelatinase
activity.
a marked reduction of 51% in the lytic activity of MMP-9
when compared with cells treated with IL-1b alone (Fig.
4B). In some experiments, lytic activities of bands migrat-
ing at 72 and 66 kD were weakly enhanced by IL-1b
treatment but remained unaffected by NO (Fig. 4A,
lower panel). As shown in Figure 5, similar results were
obtained with MCs treated with DETA-NO. DETA-
NO treatment led to a reduced gelatinolytic content of
MMP-9 in cellular supernatants in doses ranging from
100 to 500 mmol/L.
In the next step, we tested MMP gelatinolytic activities
in conditioned media from cells treated with IL-1b in
the presence of 1 mmol/L L-NMMA. In analogy to the
data obtained for MMP-9 mRNA level, gelatinase activ-
ity evoked by IL-1b treatment was amplified by 2.1 6
0.8-fold (N 5 3) used in cells treated with L-NMMA (Fig.
6). Densitometric analysis of lytical activities showed that
Fig. 7. Exogenous NO has no effect on IL-1b–induced gelatinolyticthe intensity of MMP-2 bands at 66 and 72 kD were not
MMP-9 and MMP-2 activities in cell-free incubations. MCs were incu-
significantly altered by L-NMMA. bated with vehicle (control) or with IL-1b (2 nmol/L) for 48 hours. One
hundred microliters of cell culture supernatants were collected after 48
hours of stimulation and were exposed to the indicated NO donorsEffect of exogenously added NO on MMP-9 activity
(SNAP, 500 mmol; DETA NONOate, 500 mmol/L) for the indicated
in vitro time points. Subsequently, 20 mL of treated supernatant were assayed
by SDS-PAGE zymography. The results are shown as triplicates.To evaluate whether NO directly is able to alter
MMP-9 activity, conditioned media obtained from MCs
either untreated or stimulated for 48 hours with IL-1b
Nitric oxide-mediated effects on MMP-9 and TIMP-1were treated with SNAP or alternatively with DETA-
mRNA are independent from changes in cGMPNONOate (both at 500 mmol/L) for three hours or in
A wide spectrum of physiologic actions of NO can beovernight incubations (Fig. 7). None of the conditions
explained by the activation of soluble guanylate cyclasetested had any discernible effects on activation of cyto-
most prominently through a direct binding to the en-kine-induced MMP-9 zymogen activity. Furthermore,
zyme’s prosthetic heme group. To see whether inhibitionnone of the NO donors tested had altered constitutive
of MMP-9 and TIMP-1 expression by NO is mediated bylytic activities of MMP-2. From these results, we con-
activation of soluble guanylate cyclase and subsequent
clude that NO-mediated alteration of zymogen activity cGMP formation, we tested whether exogenously ap-
is predominantly due to decreased MMP-9 expression plied cGMP analogues were able to mimic the inhibitory
but not to a direct inhibition of MMP-9 enzyme activity. effects of NO. Coincubation of cells with the membrane-
Thus far, we have not been able to check the expression permeable analogue dibutyryl cGMP did not alter the
levels of MMP-9 protein, as none of the commercially IL-1b–induced mRNA levels of either MMP-9 or
available mouse or human anti–MMP-9 antibodies TIMP-1 (Fig. 8). These findings suggest that inhibition
tested in Western blot or ELISA showed any cross-reac- of cytokine-induced MMP-9 and TIMP-1 by NO is inde-
pendent of alterations of cGMP level in MCs.tivity with the rat MMP-9 antigen.
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on cytokine-induced MMP-9 expression reported here
may prevent in a protective manner the MC from exces-
sive matrix degradation provoked by cytokines. NO ef-
fects on metalloproteinases have been described for sev-
eral cell types and were shown to differ substantially,
depending on the cell type examined. A direct stimula-
tory effect of NO on MMP-2 activity was shown in human
and bovine cartilage and chondrocytes [3], and also in
rat MCs [22]. Tamura et al demonstrated that the IL-
1b–induced increase in MMP-2 and MMP-9 activity is
mediated by NO in rabbit chondrocytes [23]. In contrast,
suppressive effects of NO on cytokine-induced proteo-
lytic activity of MMP has been reported for bovine art-
icular cartilage [24]. However, all of these studies ex-Fig. 8. Suppression of IL-1b–induced MMP-9 and TIMP-1 expression
clusively refer to NO-mediated actions on enzymaticby NO is not mediated by cGMP. MCs were stimulated for 24 hours
with the indicated concentrations of dibutyryl cGMP in the absence activity but did not investigate modulatory effects on
(2) or presence (1) of 2 nmol/L of IL-1b. Total cellular RNA was mRNA levels of the corresponding genes. In our hands,simultaneously hybridized to 32P-labeled MMP-9 and TIMP-1 probes,
NO donors had no direct effects on MMP-9 activity,as described in the Methods section. To assess for variations in RNA
loading, blots were stripped and rehybridized to a GAPDH cDNA thus suggesting that NO-mediated effects on gelatinase
probe. activity primarily result from alterations in MMP-9
mRNA levels. Possible reasons for these disparate ef-
fects of endogenously produced NO on metalloprotein-
ase activity and expression may be due to differencesDISCUSSION
in the experimental setup and especially to differentIn this study, we evaluated modulatory effects of NO
amounts of reactive oxygen derivates produced simulta-on gelatinase expression in rat MCs. These types of met-
neously with NO. In rat fibroblasts, simultaneous genera-
alloproteinases seem to be of high impact for distur-
tion of both NO and superoxide caused inhibition of
bances in the turnover and remodeling of glomerular MMP-9 activity, whereas NO by itself had no effects
ECM. Furthermore, MMPs are discussed as central me- [25]. In MCs, the ratio between NO and superoxide is
diators of the response of intrinsic MCs toward inflam- critical for the induction of apoptosis [26]. Finally, the
matory stimuli [17]. Upon treatment with diverse stimuli, local balance between NO and superoxide formation
MCs have been shown to synthesize and secrete a variety may determine the extent of ECM degradation during
of serine and metalloproteinases, including the 72 and inflammatory processes.
92 kD gelatinases MMP-2 and MMP-9, respectively [2, 13]. One further key aspect of MMP regulation is the inhibi-
Whereas MMP-2 in most nontumor and nontransformed tion of the activated enzymes by their specific inhibitors,
cell lines is constitutively expressed, MMP-9 is strongly the TIMPs. MMP-9 activity is regulated in particular by
induced by cytokines and phorbol esters [21]. Previously, TIMP-1 through a direct protein–protein interaction [1].
we have shown that cultured MCs produce high levels When looking for NO-mediated effects on cytokine-
of NO upon stimulation with proinflammatory cytokines induced mRNA levels, we found that TIMP-1 at certain
such as IL-1b and TNF-a due to increased expression time points (24 to 72 hours) follows a coordinate expres-
of iNOS [7–9]. This study provides strong evidence for sion pattern with MMP-9. A similar regulation of MMPs
a modulatory role of NO on cytokine-induced MMP-9 and their specific TIMPs has been shown for MMP-1
and to a lesser extent also on MMP-2 gene expression. and TIMP-1 [27, 28] and is thought to be a common
MMP-9 mRNA levels were detected only in low amounts mechanism for protecting tissues from overwhelming
under control conditions but were strongly increased proteolysis by fine tuning of local proteolytic activity
upon stimulation with IL-1b. Exogenously added NO, [20]. Interestingly, following short-time kinetic experi-
having weak effects on its own, was able to significantly ments (8 to 16 hours), we found that TIMP-1 mRNA is
reduce IL-1b–induced MMP-9 and MMP-2 mRNA lev- already detectable after eight hours of cytokine treat-
els. Furthermore, we demonstrate that inhibition of endo- ment, whereas MMP-9 mRNA is not detectable by
genous NO production by L-NMMA leads to a concomi- Northern blotting before 24 hours of treatment with
tant, dose-dependent potentiation of cytokine-induced IL-1b (data not shown). Moreover, we observed that
MMP-9 and TIMP-1 mRNA levels. NO modulation of the IL-1b–induced TIMP-1 mRNA
In MCs, NO acts in a positive feedback loop, regulat- level seems to be biphasic. Up to 16 hours, coincubation
ing its own synthesis by amplifying cytokine-induced of IL-1b with NO donors strongly increases the steady-
state mRNA level of TIMP-1 (data not shown). Appar-iNOS gene expression [11]. The negative effects of NO
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ently, MMP-9 and TIMP-1 are differentially regulated ultimative effect of NO-mediated down-regulation of
by NO and do not follow a similar time course that may MMP-9 and TIMP-1 expression is virtually time depen-
result in a final decrease of net protease activity. A differ- dent and therefore may have protective as well as de-
ential regulation of glomerular MMP-9 and TIMP-1 has structive consequences, depending on the time point of
also been shown in a rat model of obesity [29]. Cellular its occurrence. Further investigation of these critical time
supply with TIMPs in excess over the MMP’s expression periods in experimental models of glomerular diseases
may prevent excessive matrix degradation caused by pro- is necessary to more precisely define the therapeutic
inflammatory cytokines, and may thus be of considerable consequences of strategies based on the inhibition of
physiologic importance. The molecular mechanisms un- NO production.
derlying NO-triggered gene expression are still poorly
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In conclusion, our study provides convincing evidence APPENDIX
for a modulatory role of NO on cytokine-induced MMP-9 Abbreviations used in this article are: ECM, extracellular matrix;
and TIMP-1 expression in rat MCs. Under physiologic FCS, fetal calf serum; IL-1b, interleukin-1b, iNOS, inducible nitric
oxide synthase; L-NMMA, NG-monomethyl l-arginine; MC, mesangialconditions, a constant release of low amounts of NO
cell; MMP, matrix metalloproteinase; NF-kB, nuclear factor-kB; NO,produced by the constitutive NO synthase of the adjacent nitric oxide; NOS, nitric oxide synthase; SNAP, S-Nitroso-N-acetyl-
endothelium may suppress the expression of MMP-9, D,L-penicillamine; TIMP, tissue inhibitors of metalloproteinase;
TNFa, tumor necrosis factor-a.and thus guarantee a balanced homeostasis of glomeru-
lar architecture. By contrast, under inflammatory condi-
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